CEFALY Technology Sprl of Seraing at MEDICA 2017 in Düsseldorf -- COMPAMED Trade Fair
Manufacturers

CEFALY Technology Sprl

LIEGE Science Park, Rue Louis Plescia, 34, 4102 Seraing
Belgium

Telephone +32 4 3676722
Fax +32 4 3676702
info@cefaly.com

Hall map

MEDICA 2017 hall map (Hall 11): stand F32

Fairground map

MEDICA 2017 fairground map: Hall 11

Our range of products

Product categories

  • 01  Electromedical equipment / Medical Technology
  • 01.03  Therapie and physical medicine
  • 01.03.13  Transcutaneous nerve stimulation
  • 01  Electromedical equipment / Medical Technology
  • 01.03  Therapie and physical medicine
  • 01.03.13  Transcutaneous nerve stimulation
  • 01.03.13.01  Equipment for pain therapy, transcutaneous nerve and muscle stimulation

Equipment for pain therapy, transcutaneous nerve and muscle stimulation

Our products

Product category: Transcutaneous nerve stimulation

Cefaly 2 European Model

e-TNS (External Trigeminal Nerve Stimulation)

More Less

Product category: Transcutaneous nerve stimulation, Equipment for pain therapy, transcutaneous nerve and muscle stimulation

Cefaly 1 European Model

Current Generator for maximum skin impedance of 2.2 KΩ
Automatic treatment interruption and signal when circuit impedance higher 2.2 KΩ

More Less

Product category: Transcutaneous nerve stimulation, Equipment for pain therapy, transcutaneous nerve and muscle stimulation

Transcranial Neurostimulator

The CEFALY t-DCS is small, portable and ergonomic. It is conceived to be easily used by patients at home. Currently only available for clinical investigation.

More Less

About us

Company details

CEFALY Technology innovates in the medical domain with as main objective the Therapeutic Progress. This means that the new products must bring a benefit to the patients in comparison with existing treatments. The activity is therefore driven by patient's interest and not by the search for market shares by developing "me-too" drugs or devices.

The Therapeutic Progress can address the efficacy of the treatment in clincal practice, on the reduction of side effects, on the convenience of use or on the reduction of cost to the society and to the patients.

More Less